The Penicillins and Streptomycins dosage market in Armenia was valued at 5.1872 million USD in 2023, showing a consistent downward trend over recent years. Between 2013 and 2023, the market experienced fluctuations with a peak in 2014, yet saw a decline from 2018 onwards. The recent two-year period observes a year-on-year decrease of 2.18% in 2022 and 2.21% in 2023. For the five-year span, the compound annual growth rate (CAGR) averaged -0.94%, highlighting a gradual contraction in market value.
Future trends to monitor include potential market stabilization or further decline influenced by regulatory changes, shifts in healthcare policies, or advancements in alternative treatment options. A focus on emerging healthcare technologies and domestic production capabilities could recalibrate the market's trajectory.
How does Armenia rank in Penicillins and Streptomycins in Dosage Market Size Value?
| # | 33 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 4,303,400,000 | 2023 | +0.61% | +1.48% | View data |
| 2 | 2 United Kingdom | 730,000,000 | 2023 | -1.31% | -1.45% | View data |
| 3 | 3 France | 717,200,000 | 2023 | -1.91% | +0.034% | View data |
| 4 | 4 Italy | 622,330,000 | 2023 | -3.96% | -4.86% | View data |
| 5 | 5 Germany | 476,270,000 | 2023 | +1.03% | +1.1% | View data |
| 29 | 29 Kyrgyzstan | 10,516,000 | 2023 | -0.4% | -0.84% | View data |
| 30 | 30 Moldova | 5,776,600 | 2023 | -4.38% | -6.74% | View data |
| 31 | 31 Armenia | 5,084,600 | 2023 | -2.21% | -0.94% | |
| 32 | 32 Luxembourg | 3,435,800 | 2023 | +0.84% | +2.7% | View data |
| 33 | 33 Estonia | 2,300,800 | 2023 | -17.73% | -11.1% | View data |
